In pancreatic tumors, Ki-67 has been used as a indicator for classification of pancreatic endocrine neoplasms grade [20], and Ki-67 > 5% predicted worse recurrence free survival [21]. This evidence concerns the gene MKI67 and pancreatic neuroendocrine neoplasm.